Trending...
- Countryside Golf & Country Club general manager receives prestigious professional designation
- Better Together receives $15,000 from Gulf Coast Community Foundation to support hurricane relief
- Francesca Corbi Joins Coral Bay Recovery Clinical Team
ST. AUGUSTINE, Fla. - Floridant -- St. Augustine, FL — 10.31.24 — Kihealth, a leader in precision health technology, is excited to announce that it has successfully completed its pre-submission meeting with the U.S. Food and Drug Administration (FDA) regarding its innovative Beta First test. This milestone marks a significant step forward in the company's mission to revolutionize metabolic health assessment.
The Beta First test leverages cutting-edge technology to provide accurate diagnostics for beta cell function, aiming to enhance early detection and treatment of diabetes. The pre-submission meeting with the FDA was an opportunity for Kihealth to engage with regulatory experts, gain valuable feedback, and clarify the pathway for the test's submission.
"We are thrilled to have completed this important milestone with the FDA," said Jenna Anderson, CEO at Kihealth. "The insights gained from this meeting will be instrumental as we move forward with our efforts to bring the Beta First test to market. Our commitment to improving patient outcomes through innovative diagnostic solutions remains our top priority."
More on The Floridant
Kihealth anticipates that the Beta First test will not only assist healthcare providers in making more informed treatment decisions but also empower patients by providing them with critical information about their metabolic health. This aligns with Kihealth's dedication to preventative care and personalized medicine.
The company plans to submit its DeNovo application to the FDA in the coming months, with the goal of making the Beta First test available to healthcare professionals and patients as soon as possible.
For more information about Kihealth and its pioneering diagnostic solutions, please contact the company at info@kihealth.com.
About Kihealth
Kihealth is dedicated to advancing precision health through innovative technology and diagnostics. By focusing on metabolic health and diabetes management, Kihealth aims to empower both healthcare providers and patients with the tools needed for improved health outcomes.
Media Contact
info@Kihealth.com
www.kihealth.com
The Beta First test leverages cutting-edge technology to provide accurate diagnostics for beta cell function, aiming to enhance early detection and treatment of diabetes. The pre-submission meeting with the FDA was an opportunity for Kihealth to engage with regulatory experts, gain valuable feedback, and clarify the pathway for the test's submission.
"We are thrilled to have completed this important milestone with the FDA," said Jenna Anderson, CEO at Kihealth. "The insights gained from this meeting will be instrumental as we move forward with our efforts to bring the Beta First test to market. Our commitment to improving patient outcomes through innovative diagnostic solutions remains our top priority."
More on The Floridant
- Shoe Elegance Relaunches as an Online Boutique, Reviving Timeless Style and Sophistication
- CULTURE & COCKTAILS At The Ben Returns on Jan 6 with Award-Winning Comedy Writer ALAN ZWEIBEL
- Naughty Nevada Band Launches a Bold New Website Design
- Inspiring the Full Arch Industry: Dr. James Fetsch Speaks At The Full Arch Growth Conference 2024
- BHRT Training Academy Announces inaugural BHRT 'Symposium at Sea 2025' for Healthcare Providers
Kihealth anticipates that the Beta First test will not only assist healthcare providers in making more informed treatment decisions but also empower patients by providing them with critical information about their metabolic health. This aligns with Kihealth's dedication to preventative care and personalized medicine.
The company plans to submit its DeNovo application to the FDA in the coming months, with the goal of making the Beta First test available to healthcare professionals and patients as soon as possible.
For more information about Kihealth and its pioneering diagnostic solutions, please contact the company at info@kihealth.com.
About Kihealth
Kihealth is dedicated to advancing precision health through innovative technology and diagnostics. By focusing on metabolic health and diabetes management, Kihealth aims to empower both healthcare providers and patients with the tools needed for improved health outcomes.
Media Contact
info@Kihealth.com
www.kihealth.com
Source: Kihealth inc.
Filed Under: Health
0 Comments
Latest on The Floridant
- Sequentex Achieves Prestigious Women-Owned Small Business (WOSB) Certification
- Premier Mobile Health Services founder, CEO named Nonprofit Executive of the Year
- Christmas comes early as Shop with a Sheriff makes holiday season brighter for Naples families
- Shape the Future of OpenSSL: Election Period Open Now!
- LIB Empowers Uzbekistan's Automotive Industry: A New Era of Quality Assurance
- Nader Sculpture Park Officially Opens in Miami Design District During Miami Art Week
- Delray Beach's Grounded Visions Launches Integral Eye Movement Therapy
- TijaraIQ.com Launches as Iraq's Free Marketplace for Buying, Selling, and Creating Opportunities
- Big News!! Best Sac Homes Group Partners with LPT Realty
- Juventix Regenerative Medical PRP Highlighted in University-Published Research Study
- Blue Point USA LLC Secures GSA Multiple Award Schedule Contract with Assistance from Government Marketplace LLC
- Klime Kovaceski Enlists Dimi De San for Captivating Track Odyssey on His 14th Album Release in Less
- Dale Sorensen Real Estate Names Donna Browning Vice President of Sales, Announcing Her Return to the Company
- SmallPC Launches Redesigned Website, Announces Partnership with Cincoze, & Expands Product Offering
- Dr. Barrie Matthews of Big Sky Smile Center Speaks at the Full Arch Growth Conference, Inspiring Dentists Nationwide
- The Florida Forum Speaker Series to Welcome Deepak Chopra
- Tommy Bohanon Foundation collects 600 toys, raises $20,000 at 2024 Softball Tournament
- Project Astral NFT Drop by AI Film Guerrillas Released via Ethereum on Base Network
- Dr. Sathish Palayam Speaks at the Full Arch Growth Conference, Sharing Insights to Revolutionize Patient Care!
- InStockRx Wins 1871 Supply Chain Pitch, Announces GS1 Partnership